MedTrace Logo

A Follow-up Study to Investigate the Effects of a New Infant Formula on Growth and Body Composition

NCT02594683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 359

Last updated 2021-10-18

No results posted yet for this study

Summary

A follow-up study of a randomised, controlled, study to investigate the effects of a new infant formula given in the first 12 months of life on growth and body composition up to 5 years of age

Conditions

  • Healthy

Sponsors & Collaborators

  • National University Hospital, Singapore

    collaborator OTHER

  • KK Women's and Children's Hospital

    collaborator OTHER_GOV

  • Danone Asia Pacific Holdings Pte, Ltd.

    lead INDUSTRY

Principal Investigators

  • Oon Hoe Teoh, MBBS · KK Women's and Children's Hospital

  • Jian Yi Soh, MBBS · National University Hospital, Singapore

Eligibility

Min Age
3 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-09-12
Completion
2020-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02594683 on ClinicalTrials.gov